Exploring the crosstalk between familial and idiopathic Parkinson’s (in person talk)

Dr Lewis has been investigating the causes of neurodegeneration for two decades, working on Alzheimer’s disease, the Prion diseases and, since 2005, Parkinson’s disease. His major research interest is understanding how mutations associated with neurodegenerative diseases alter the way brain cells work, causing them to die. He studied biochemistry at the University of Manchester, working for a year at the Mayo Clinic in Florida with Dr Todd Golde on the molecular mechanisms of Alzheimer’s disease. He undertook graduate studies at the MRC Prion Unit, supervised by Dr Graham Jackson and Professor Tony Clarke, before moving to the National Institute on Aging in Bethesda were he started working on the cell biology of Parkinson’s disease. He returned to the UK in 2007 to take up a Brain Research Trust fellowship at the UCL Institute of Neurology. From 2010 to 2015 he was a Parkinson’s UK research fellow, investigating mutations in the LRRK2 gene, establishing his own group at the University of Reading in 2013 as an Associate Professor. He moved to the Royal Veterinary College in 2020.